Literature DB >> 19185349

Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit.

S Schelenz1, R A Barnes, C C Kibbler, B L Jones, D W Denning.   

Abstract

OBJECTIVE: The objective of this study was to audit the compliance and implementation of the British Society for Medical Mycology standards of care for patients with invasive infections in UK hospitals.
METHODS: A multidisciplinary audit questionnaire regarding the processing of microbiology and histopathology specimens, radiology imaging and clinical management of patients with invasive fungal infections was distributed to UK hospitals.
RESULTS: The study has shown that speciation of Candida and Aspergillus isolates from sterile sites was performed in 42-98% of hospitals. Microscopy of bronchoscopy specimens was not undertaken in 13 of 62 (21%) laboratories. Cryptococcal culture and antigen were undertaken routinely in abnormal CSF in 40-75% and 31-83% of at-risk patients but only in 12% of abnormal CSFs in patients without risk factors. Detailed fungal morphology was provided by <50% of histopathology departments. Most hospitals provided a timely HRCT or MRI on patients suspected to have an invasive fungal infection, but early treatment failed to occur in 15% of hospitals. In patients presenting with candidaemia, central venous catheters (CVC) were not changed routinely within 48h in 15%.
CONCLUSION: Improvement in microbiology and histopathology specimen processing as well as rapid interventions such as initiation of anti-fungal therapy or CVC line removal could improve diagnostic rates and clinical outcomes of invasive fungal infections.

Entities:  

Mesh:

Year:  2009        PMID: 19185349     DOI: 10.1016/j.jinf.2008.12.006

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  A 6-year antifungal stewardship programme in a teaching hospital.

Authors:  V Mondain; F Lieutier; L Hasseine; M Gari-Toussaint; M Poiree; C Lions; C Pulcini
Journal:  Infection       Date:  2013-03-06       Impact factor: 3.553

Review 2.  Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.

Authors:  L Drgona; A Khachatryan; J Stephens; C Charbonneau; M Kantecki; S Haider; R Barnes
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-12       Impact factor: 3.267

Review 3.  Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox.

Authors:  Aidan Kane; Dee A Carter
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-14

4.  Candida nivariensis isolated from a renal transplant patient with persistent candiduria-Molecular identification using ITS PCR and MALDI-TOF.

Authors:  Rebecca L Gorton; Gareth L Jones; Christopher C Kibbler; Sophie Collier
Journal:  Med Mycol Case Rep       Date:  2013-10-25

Review 5.  Application of Culture-Independent Rapid Diagnostic Tests in the Management of Invasive Candidiasis and Cryptococcosis.

Authors:  Michael A Pfaller
Journal:  J Fungi (Basel)       Date:  2015-08-31

6.  A novel renal epithelial cell in vitro assay to assess Candida albicans virulence.

Authors:  Edina K Szabo; Donna M Maccallum
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.